This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Frank Sacher - Innovator in Pharmaceutical Research
Introduction: Frank Sacher is an accomplished inventor based in Berlin, Germany. He is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. With a focus on innovative solutions for healthcare, Sacher is dedicated to advancing medical research and developing new treatments.
Latest Patent Applications: Frank Sacher has been involved in several significant patent applications. One of his latest applications is titled "Furoindazole Derivatives as GPR84 Antagonists." This invention covers furoindazole compounds of general formula (I), which are designed for the treatment or prophylaxis of various autoimmune diseases, including multiple sclerosis, psoriasis, and rheumatoid arthritis. Another notable application is "Inhibitors of IL-11 or IL-11Ra for Use in the Treatment of Abnormal Uterine Bleeding." This invention relates to agents that can inhibit the action of IL-11 and/or IL-11RA, addressing conditions such as heavy menstrual bleeding and endometriosis.
Conclusion: Frank Sacher's contributions to pharmaceutical research highlight his commitment to developing innovative treatments for complex medical conditions. His work at Bayer Aktiengesellschaft continues to pave the way for advancements in healthcare.